Recent Finacing
Recent Raise
Pulmokine is a Rensselaer, NY-based biopharmaceutical company developing PK10571, a PDGF receptor kinase inhibitor targeting pulmonary arterial hypertension, with IND submission planned and Phase 1 trials intended.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor